RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Special Edition VGR: COVID-19 Vaccine Update

by David Rubin | April 2, 2021 | In the Press | 0 Comments

Click here to watch Dr. David Rubin and his colleagues explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID-19 vaccine special issues in underrepresented minorities.

Dr. Rubin Disscusses Probiotics, Prebiotics, and Why Your Gut is a Window to Your Overall Health

by dtrubin | July 30, 2018 | In the Press, Nutrition | 0 Comments

"Your intestines are the center of the universe." Listen to Dr. Rubin's appearance on WGN Nightside radio discussing the gut microbiome, IBD and other human diseases. You can find the full recording here.

How IBD Can Affect Patients’ Career and School Choices

by dtrubin | December 3, 2019 | QoL, Rubin's Reflections | 0 Comments

IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...

Dr. David T. Rubin on Transabdominal Ultrasound for IBD: Lessons from STARDUST Substudy on Ustekinumab

by David Rubin | January 19, 2024 | In the Press | 0 Comments

Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an approach to visualizing the intestines using a transabdominal ultrasound probe to provide real-time information. But could...

Dr. David T. Rubin on “How I Treat Ulcerative Colitis”

by David Rubin | April 23, 2024 | In the Press, Presentations | 0 Comments

Dr. Rubin provides an in-depth look at the treatment of ulcerative colitis, from recent advances in therapeutic agents to setting patient expectations, positioning treatments, and monitoring for disease remission or progression. Click here for the full talk from the...

Dr. David T. Rubin Hosts Pearls from the Pros on IBD Management

by David Rubin | March 1, 2022 | In the Press | 0 Comments

Dr. Rubin hosted four episodes of MedEd Talks Gastroenterology's Pearls from the Pros on IBD Management, featuring several colleagues to discuss best practices in using different classes of IBD therapies. Dr. Rubin spoke with Dr. Bruce Sands, Gastroenterologist and...

Endoscopic Phenotype: A Potential Predictor of Cuffitis Risk

by dtrubin | January 27, 2020 | In the Press | 0 Comments

Advanced IBD Fellow Shintaro Akiyama, MD, PhD presented a Quick Shot of his abstract on pouchitis involving the rectal cuff at Crohn's and Colitis Congress. MedPage Today reported the results in the article here and Healio reported the results here. Very proud of Dr....

Pursuing a Gut Feeling: Exploring Immune Cell Trafficking Inhibitors to Treat IBD

by David Rubin | March 2, 2021 | In the Press | 0 Comments

Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

by David Rubin | July 30, 2021 | Rubin's Reflections | 0 Comments

A Cure for Crohn’s: How Close Is It?

by David Rubin | October 20, 2020 | In the Press | 0 Comments

Dr. David Rubin discusses advancements in Crohn's disease treatment. "And while there isn’t a cure for Crohn’s yet, we’ve come a long way in how we assess and treat it. Treatment used to involve trying a new medicine or therapy and waiting to see if it made you feel...